Skip to content
Medical Health Aged Care

Neglected disease ‘must come out of shadows’ as experts call for National Strategy

Eczema Support Australia 3 mins read

An extremely common yet often dismissed condition that causes undue pain and distress to millions of Australians and costs the economy $4 billion a year is the focus of a new report calling for a National Strategy to prevent Australians being lost in a treatment maze.

Launched by Eczema Support Australia, with input from a multidisciplinary group representing nurses, psychologists and GPs, and supported by the Australasian College of Dermatologists, ‘The Burden of Eczema – Evidence for a National Strategy’ reveals that up to three million Australians – including one in three children aged 6 years or younger – are afflicted by eczema which causes severe pain, distress and sleep disruption, yet many are undertreated due to a nationwide shortage of dermatologists and lack of training for general practitioners.

Eczema Support Australia Managing Director, Melanie Funk said that the report “should act as an SOS call to Government to establish a National Eczema Strategy to urgently address the suboptimal treatment of eczema.”

The major report reveals that adults with eczema are three times more likely to suffer depression than those without the condition, and more than one-in-five adults with eczema consider suicide, yet only 3% of impacted adults reported receiving information about psychological help from their GP.

Each year, Australians incur up to $336 million out-of-pocket costs for medical visits, plus a further $1.2 billion for medications, emollients, special food and clothing to manage eczema.

In a recent survey, three quarters of Australians with eczema said their family was impacted financially by the condition, with many saying they use savings, borrow money, and spend less on food and other essentials to pay for eczema management.

“As a mum with twin boys diagnosed with eczema fourteen years ago, it was shocking to me how little support and patient education there was, made all the worse because eczema never sleeps – so neither does anyone dealing with eczema,” said Ms Funk who set up Eczema Support Australia to provide connection and understanding to other Australians impacted by the condition.

“Fast forward fourteen years and nothing has changed. We hear the same cry for help repeatedly from those contacting us, who are driven to desperation by pain and exhaustion. Many do not have timely access to specialists, and many suffer from a huge variation in care across Australia,” Ms Funk explained.

“For a condition that is so common and requires such a high level of self-management, it is truly shocking there isn’t more support and education, and so many are lost in a treatment maze,” said Ms Funk.

“We desperately need a National Eczema Strategy in Australia to improve the lives of those struggling with the consequences of eczema which include sleep deprivation, anxiety, depression, headaches, and thousands of dollars of out-of-pocket costs from managing the condition.”

Eczema Support Australia has written to the Federal Health Minister and Department of Health and Aged Care to share the report’s findings and to seek their support for establishing a National Eczema Strategy. The organisation has also formalised its call via a petition to the House of Representatives. The e-petition closes on 6 October 2023.

The Australasian College of Dermatologists, which authored the report’s foreword, endorsed the call for a National Eczema Strategy and added their support to “bringing eczema out of the shadows and showing that Australia can, and must, do better”.

Dr Adriene Lee, President of the Australasian College of Dermatologists said, “A coordinated response will go a long way to ensuring all Australians with this condition have optimal and equitable access to treatment and care, which is why the College has no hesitation in supporting this report – and the evidence for a National Eczema Strategy.

“The widespread underuse of topical corticosteroids due to ‘steroid phobia’ has long been a concern of the College but without a coordinated effort to change these perceptions using evidence-based information, Australians will continue to experience avoidable and unnecessary severe disease flares.

“As well as education and awareness raising for general practice and pharmacy, it is also critical to ensure access to specialist care by addressing the dermatology workforce shortage through federal and state investment in dermatology services and training.” she said.

The report includes a 10-point list for a National Eczema Strategy to address, starting with standardising the care of Australians with eczema so those impacted receive the right medicine and services, including psychological support, at the right time, regardless of where they live.

Other areas to address include countering ‘steroid phobia’ to prevent the underuse of corticosteroid therapy which leads to unnecessary eczema flare-ups; ensuring all Australians with eczema benefit from timely access to treatment; increasing health literacy for those affected; funding patient support services; bolstering dermatology training in general practice; addressing a nationwide shortage of dermatologists; and establishing an eczema registry.

‘The Burden of Eczema – Evidence for a National Strategy’ is available at www.eczemasupport.org.au/national-strategy

To sign the e-petition calling for a National Eczema Strategy, go to https://www.aph.gov.au/e-petitions

If you’re feeling overwhelmed by eczema, you are not alone. Visit www.eczemasupport.org.au, connect with us on social media, email contact@eczemasupport.org.au, or call Lifeline on 13 11 14 (24 hours a day).


Contact details:

Media Contact: Fiona Beveridge 0405 902 826

Media

More from this category

  • Medical Health Aged Care, Science
  • 19/04/2024
  • 15:00
Monash University

Large-scale genetic study finds new link between Irritable Bowel Syndrome and the cardiovascular system

New research published today in the journal Cellular and Molecular Gastroenterology and Hepatology sheds light on disease mechanisms common to irritable bowel syndrome (IBS) and cardiovascular diseases (CVD). Led by Dr Leticia Camargo Tavares, a Postdoctoral Fellow at the Hypertension Research Laboratory within Monash University’s School of Biological Sciences, the study reveals novel insights into the genetic underpinnings of IBS, offering potential avenues for therapeutic intervention. IBS is one of the most prevalent gastrointestinal disorders globally, affecting up to 10 per cent of the population, with a disproportionate impact on women. It is characterised by a complex range of symptoms…

  • Medical Health Aged Care
  • 19/04/2024
  • 11:13
Gilead Sciences Australia

Australian community organisations addressing viral hepatitis receive AU$400,000 via global Gilead ALL4LIVER Grant program

– Gilead Sciences joins forces with World Hepatitis Alliance and experts to drive progress on viral hepatitis elimination targets – – Australian initiatives well represented in Gilead’s US$4 million global fund to empower local communities in the fight against viral hepatitis – Melbourne, Australia, 19 April 2024 – Today, on World Liver Day, Gilead Sciences Australia has announced nine local community organisations addressing viral hepatitis will receive a combined AU$400,000 via the global Gilead ALL4LIVER Grant. The recipients were selected by an independent external review panel of global experts, including the World Hepatitis Alliance. Australia has committed to achieving the…

  • Contains:
  • Medical Health Aged Care
  • 19/04/2024
  • 08:15
Royal Australian College of GPs

“Give us a break”: GPs call for key improvements to the Hospital in the Home program

The Royal Australian College of GPs (RACGP) is urging the federal Government to help GPs and patients take full advantage of the Hospital in the Home program. It comes following College President, Dr Nicole Higgins, writing to the Minister for Health and Aged Care, Mark Butler, calling for action. Under Hospital in the Home, patients receive acute care in the comfort of their home, or another suitable location. RACGP President Dr Nicole Higgins called for change. “Inconsistent guidance, billing confusion and communication issues are a headache for GPs and patients. These issues are holding back the Hospital in the Home…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.